Stock Market Today (Sept. 28, 2026): S&P 500 and Nasdaq Fall as Treasury Yields and Oil Rekindle Inflation Fears -( $AEO $AMC $AMWL $BE $KOD $LPL $MODD $NVDA $SER $SPCX $VIX )

U.S. stocks closed lower Monday as rising Treasury yields and volatile oil prices revived concerns about inflation and higher-for-longer interest rates. The S&P 500 fell 0.77%, the Dow Jones Industrial Average declined 0.67%, the Nasdaq Composite lost 0.92% and the Russell 2000 dropped 0.65%, according to end-of-day market data. The session’s central message was that resilient economic activity is no longer an unqualified positive for risk assets. Strong Texas manufacturing data, elevated energy prices and higher production costs reinforced the possibility that the Federal Reserve may need to maintain restrictive monetary policy.

U.S. Market Closing Levels

The Russell 2000 showed a minor variation between the supplied market captures. The table uses the 2,819.06 reading displayed in the more complete closing dashboard.

Why Stocks Fell

Stocks and Treasury bonds declined together as oil-market uncertainty revived concerns that elevated energy prices could slow disinflation. President Donald Trump’s rejection of Iran’s conditional proposal concerning the Strait of Hormuz initially sent crude prices sharply higher, although oil later surrendered most of its intraday advance. Reports that Saudi Arabia had restored substantial flows through its East-West pipeline helped ease immediate supply fears. Nevertheless, November WTI crude finished at $92.94 per barrel, leaving energy costs high enough to remain a potential source of inflation pressure. The bond market presented the more significant challenge for equities. The benchmark 10-year Treasury yield climbed to 5.24%, increasing borrowing costs and reducing the present value investors place on future corporate earnings. That dynamic is particularly important for technology, housing, infrastructure and other rate-sensitive industries. Companies whose valuations depend heavily on profits expected several years into the future generally face greater pressure when risk-free interest rates rise. The Cboe Volatility Index gained 8.33% to 16.11, reflecting increased demand for equity-market protection, although the index remained below levels normally associated with severe market stress.

Macroeconomic Report

The September Texas Manufacturing Outlook Survey delivered a stronger-than-expected reading on factory production but also revealed persistent cost pressures. The Federal Reserve Bank of Dallas reported that its production index jumped to 29.5 from 16.1 in August, indicating a robust acceleration in Texas manufacturing output. The new-orders index rose to 30.7 from 22.0, while the employment index improved to 15.1 from 8.0. The general business activity index slipped to 9.8 from 11.6 but remained positive for a third consecutive month. The result also exceeded the 6.0 consensus estimate reported ahead of the release. Inflation-sensitive components of the survey moved higher. The raw-materials price index increased to 52.2 from 44.1, while the finished-goods price index rose to 27.6 from 22.7. Wages and benefits also increased, pointing to continued pressure on operating expenses.

What the Data Means

The Dallas Fed report contained a difficult combination for financial markets: faster production and stronger demand alongside rising input and labor costs. The improvement in manufacturing activity supports the economic-growth outlook and could benefit industrial companies. However, stronger demand and higher prices may make it harder for inflation to return sustainably to the Federal Reserve’s target. Because the Dallas Fed survey covers one region, many should avoid treating it as a definitive national signal. Even so, the strength in production and new orders makes upcoming national manufacturing, employment and inflation reports more consequential for interest-rate expectations.

Treasury Yields Pressure Growth Stocks

The Nasdaq Composite was the weakest major index, falling 0.92%, as the increase in Treasury yields weighed on technology and other long-duration growth stocks. When bond yields rise, investors can earn more from comparatively lower-risk government securities. That can reduce the valuation premium investors are willing to pay for high-growth companies, particularly those financing large artificial-intelligence, cloud-computing and data-center investments. The pressure was not uniform. Nvidia Corporation (NASDAQ: NVDA) gained roughly 2.7% after authorizing an additional $150 billion in share repurchases and introducing an open platform focused on AI-agent security. Nvidia’s strength helped offset weakness elsewhere in the semiconductor and AI-infrastructure sectors, but it was not enough to prevent the broader Nasdaq from closing lower.

Major Stock Movers

Boeing Falls on Certification Delay

The Boeing Company (NYSE: BA) dropped more than 6% after the Federal Aviation Administration said certification of the 737 Max 10 would be delayed while regulators evaluate a software problem. The issue could interrupt automated landing guidance when pilots perform a go-around following an aborted landing attempt. Boeing disclosed the software problem to regulators and said it would continue following the FAA’s direction as the certification review proceedsBoeing had expected the Max 10—the largest aircraft in the 737 Max family, to receive regulatory approval in the coming weeks. The delay creates additional uncertainty for Boeing and airline customers waiting for the aircraft.

Kodiak Sciences Surges

Kodiak Sciences Inc. (NASDAQ: KOD) surged approximately 173% to $88.27 after reporting positive results from its pivotal Phase 3 DAYBREAK study in wet age-related macular degeneration. Both Zenkuda and tabirafusp-ted met the trial’s primary endpoints by producing one-year vision improvements that were non-inferior to aflibercept. Kodiak also reported that 54% of patients receiving Zenkuda achieved a six-month dosing interval under the trial’s retreatment criteria.The potential for less-frequent dosing is commercially significant because it could reduce the treatment burden for patients, physicians and caregivers. Kodiak plans to present data from five positive Phase 3 studies to regulatory authorities during the fourth quarter of 2026.

MongoDB Declines

MongoDB Inc. (NASDAQ: MDB) fell after Chief Executive CJ Desai agreed to leave the database-software company and join Meta Platforms Inc. (NASDAQ: META) as chief enterprise platform officer. Leadership transitions can create near-term uncertainty, particularly for enterprise-software companies facing rapidly changing customer requirements and growing competition in artificial-intelligence infrastructure.

Roblox Slips After Downgrade

Roblox Corporation (NYSE: RBLX) declined after Jefferies downgraded the stock to underperform. The firm argued that investor expectations for bookings growth had moved ahead of the company’s likely operating performance. The downgrade highlighted a broader issue affecting high-valuation consumer technology companies: strong engagement does not always translate into equally strong revenue growth or operating leverage.

Apple Faces Patent Verdict

Apple Inc. (NASDAQ: AAPL) entered the week facing a jury award of more than $5.7 billion to privately held Taction Technology in a patent-infringement case involving haptic-feedback technology. The jury concluded that Apple infringed claims from two Taction patents connected to haptic functions used in iPhones and Apple Watches. However, the jury did not find that Apple’s infringement was willful. Apple said its Taptic Engine operates differently from Taction’s technology and announced plans to appeal the verdict. The appeal process could take years, meaning the final financial impact remains uncertain.

AMC Refinances Debt

AMC Entertainment Holdings Inc. (NYSE: AMC, $3.29, +11.90%) priced $2 billion of 8.875% first-lien notes due in 2031 and an $850 million first-lien term loan carrying an interest rate of SOFR plus 4.50%. The term loan was priced with a 1.50% original-issue discount. Together with a previously announced $1.12 billion second-lien facility involving Deutsche Bank AG (NYSE: DB), the transactions are expected to close around October 5, subject to customary conditions. The refinancing extends AMC’s debt-management efforts, but the interest rates illustrate the high cost of capital facing leveraged companies when benchmark yields remain elevated.

Iowa Steel Investment

President Trump announced a planned $15 billion investment by privately held Mesabi Metallics to construct a steel plant in Iowa. The project is expected to begin production in 2030, produce approximately 7.5 million tons of steel annually during its first phase and eventually reach 10 million tons of annual capacity. The White House said the plant could support between 5,000 and 6,000 construction jobs and at least 1,750 permanent positions. The Iowa facility would use iron ore from Mesabi Metallics’ new $2.5 billion mining operation in Minnesota. The vertically integrated model is intended to keep mining, processing and steel production within the United States. The announcement supports the administration’s domestic-manufacturing agenda, although the project’s targeted 2030 production date means its economic impact will depend on financing, construction execution and future steel demand.

LeBron James Boosts Business

LeBron James’ move to the Philadelphia 76ers is already producing measurable commercial benefits for the NBA franchise. Publicly traded ticket marketplace StubHub Holdings Inc. (NYSE: STUB) said tickets for the 2026-27 Sixers season were selling at roughly seven times the previous year’s pace. The Sixers reportedly moved from 22nd to first among NBA teams in ticket sales across home and road games. Philadelphia home-game tickets averaged approximately $282 during the comparable sales window, up from $107 one year earlier. Searches for Sixers games also represented a much larger share of NBA ticket searches following James’ arrival. Bloom Energy Corporation (NYSE: BE) became the 76ers’ new jersey-patch partner, replacing privately held Crypto.com. The multiyear agreement reportedly has an annual value exceeding $30 million and includes a seven-figure community investment in the Philadelphia region. Fanatics, a privately held sports-merchandise company, said James became its top-selling athlete across all sports after announcing his move to Philadelphia. More than 200,000 Topps Now cards connected to the announcement were also purchased. The response demonstrates how a globally recognized athlete can affect ticket pricing, merchandise sales, sponsorship revenue, television exposure and regional economic activity before the regular season begins.

SpaceXAI Reaches Orbit

Space Exploration Technologies Corp. (NASDAQ: SPCX) achieved a major technical milestone when its Starship rocket reached orbit for the first time during its 14th test flight. Starship deployed 26 next-generation Starlink V3 satellites, marking the rocket’s first operational orbital payload. The spacecraft completed the mission despite an engine problem encountered during flight. The mission advances SpaceXAI’s effort to make Starship a routine launch system for larger satellite deployments. It also supports the company’s longer-term involvement in NASA’s Artemis lunar program SpaceX began trading publicly on Nasdaq under the ticker SPCX in June 2026 after completing its combination with xAI.

AI Safety Investigation

SpaceXAI’s technical milestone coincided with increased regulatory scrutiny of its artificial-intelligence operations. The New York City Council subpoenaed Elon Musk or another SpaceXAI representative to testify at an October 5 hearing examining AI-related risks involving public safety, cybersecurity, privacy and economic stability. The council said it could seek judicial enforcement and civil-contempt remedies if the company does not comply. Meta Platforms Inc. (NASDAQ: META) agreed to participate, while Alphabet Inc. (NASDAQ: GOOGL) subsidiary Google and privately held OpenAI and Anthropic also confirmed attendance following subpoena warnings. The investigation illustrates the two-sided investment case surrounding advanced AI. Rapid product development can create new markets, but it also increases legal, regulatory and governance exposure.

American Eagle Campaign

Veteran marketer Mark Penn defended the attention generated by American Eagle Outfitters Inc.’s (NYSE: AEO., $17.31, +4.40%) Sydney Sweeney denim campaign. Penn, the founder and chief executive of Stagwell Inc. (NASDAQ: STGW), said the publicity created by the campaign was highly valuable despite the controversy surrounding its wordplay involving “jeans” and “genes.” American Eagle reported more than 40 billion impressions and over 700,000 new customers across the Sweeney and related celebrity campaigns. The campaign demonstrates the potential reach of controversy-led marketing, but it also highlights reputational risk. Penn previously served as chief strategy officer at Microsoft Corporation (NASDAQ: MSFT).

Gold and Bitcoin Decline

Gold fell 3.80% to $4,157.20 despite geopolitical uncertainty. The decline reflected the impact of rising Treasury yields and a stronger U.S. dollar. Because gold does not pay interest, higher bond yields increase the opportunity cost of holding the precious metal. Bitcoin declined 1.21% to $83,506.11, showing that the risk-off move extended beyond equities. Its weakness alongside stocks suggests investors treated the cryptocurrency as a risk-sensitive asset during Monday’s session rather than as a defensive alternative.

What Many Should Watch

Many will focus on several developments during the remainder of the week:

• PCE inflation: The Federal Reserve’s preferred inflation measure could influence expectations for the next policy decision.
• National manufacturing data: Investors will look for evidence that the strength reported by Texas manufacturers is spreading across the country.
• September employment report: Payroll growth, unemployment and wages will help determine whether labor-market conditions remain inflationary.
• Treasury yields: A sustained 10-year yield above 5.2% would remain a headwind for growth stocks, homebuilders and highly leveraged companies.
• Oil prices: Further escalation involving Iran or the Strait of Hormuz could increase the energy-related inflation premium.
• Corporate catalysts: Boeing’s certification timeline, Kodiak Sciences’ regulatory plans and SpaceXAI’s Starship program could drive additional company-specific volatility.

VP Watchlist Updates

Amwell® (NYSE: AMWL)

Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, closed at $13.44, +.07%.

AMWL announced (Sept 8) announced the Department of Veterans Affairs (VA) has declared its intent for the Company to deploy its virtual health platform within the VA enterprise and help power the modernization of the VA’s digital health infrastructure. The VA anticipates the Amwell platform will support a broad range of clinical services, enhance care coordination, and improve access for our Veterans across the VA enterprise. The Letter of Intent follows a comprehensive evaluation process by the VA, in which it determined that Amwell’s virtual health platform aligns with the Department’s strategic objectives to expand access to high-quality, secure, and reliable virtual care services for Veterans nationwide through the VA’s current electronic health record modernization efforts. Specifically, the capabilities Amwell demonstrated in scalable video consultations, interoperability, cybersecurity compliance, and support for integrated care delivery were significant factors in this determination.

Amwell® has received Frost & Sullivan’s 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell’s ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions.

The Company also reiterated recently its objective to achieve positive cash flow from operations in the fourth quarter of 2026.

Serina Therapeutics (NYSE: SER)

Serina Theraeuptics (NYSE: SER, $2..01) is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ PlatformTM provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology.

On Thursday, September 24, 2026, Serina CEO Steve Ledger discussed discuss Serina’s programs’ progress during Tribe Public’s “A New Approach to Advanced Parkinson’s Disease: Serina Discusses SER-252’s Clinical Progress”webinar, followed by a live Q&A. You may view it below.

SER announced (Sept. 9) that the independent Safety Monitoring Committee (SMC) has completed its blinded review of Cohort 1 of the ongoing Phase 1b registrational study of SER-252 in patients with advanced Parkinson’s disease and recommended that the study advance to Cohort 2. Cohort 1 evaluated the lowest dose level in the single-ascending-dose portion of the study. In addition to supporting continued dose escalation, blinded Cohort 1 observations showed a pharmacokinetic profile consistent with the sustained apomorphine exposure SER-252 is designed to provide and included sustained periods of improvement in motor function in individual patients on exploratory clinical measures.

Hudson Pacific Properties (NYSE: HPP)

Hudson Pacific Properties (NYSE: HPP, $11.50) is a real estate investment trust serving dynamic tech and media tenants in global epicenters for these synergistic, converging and secular growth industries. Hudson Pacific’s unique and high-barrier tech and media focus leverages a full-service, end-to-end value creation platform forged through deep strategic relationships and niche expertise across identifying, acquiring, transforming and developing properties into world-class amenitized, collaborative and sustainable office and studio space. HPP turned in a quarter ( Aug. 5) that suggests the office malaise is not over, but it may finally be meeting resistance. Revenue came in above Wall Street’s expectations, occupancy moved higher for a fourth straight quarter, and management raised full-year guidance, a combination that does not make for a triumphant victory lap, but it does make for a more credible turnaround narrative. Learn more.

Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Inc. (EPRX, $8.21, +2.50%), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (Aug. 13) positive results from a new analysis of the RESOLVE study examining the effect of EP-104GI on symptom severity, including for the first time an analysis of the effect of EP-104GI on odynophagia (pain when swallowing). This is important because odynophagia scoring is a component of Dysphagia Symptom Questionnaire (DSQ), a commonly used patient reported outcome used in pivotal clinical trials in EoE patients.

Modular Medical, Inc. (NASDAQ: MODD)

Modular Medical, Inc. (NASDAQ: MODD, $2.005), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, announced (September 4) that it has secured a contract with a national U.S. pharmacy benefit manager (PBM) in the United States. Pursuant to the contract, the Company’s Pivot insulin delivery system is now available through the national PBM. The Company believes the engagement with this national PBM represents a significant step forward in broadening patient access to the Company’s Pivot tubeless patch pump and will further validate the Pivot pump as an accessible therapeutic option for people living with diabetes.

MODD announced (September 3) that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system, further expanding the system’s functionality and providing users with greater flexibility and customization options in bolus dosing, an enhanced user-interface (UI), and other software upgrades.

MODD CEO, Jeb Besser, co-hosted a Tribe Public’s CEO Presentation and Q&A Webinar Event titled “The Road To Revenue: Modular Medical’s Strategy For Launching Pivot,” that was held Friday, September 4, 2026 (8:30am PT / 11:30 am ET). You may watch the event video below now if you missed it below now.

MODD announced (Aug. 3) plans to initiate the first phase of commercialization of its Pivot tubeless patch pump across five strategically selected U.S. markets beginning in October 2026. The initial rollout will include Atlanta, Cincinnati/Lexington, Dallas, Houston, and Philadelphia, representing a foundational step in the Company’s capital efficient commercialization strategy with its mission to expand access to simplified insulin delivery solutions for all people living with diabetes.

MODD recently (July 22) announced the formation of its Pivot Innovation Council, a cross-functional group of leading clinicians and healthcare experts established to help guide the company’s clinical and commercial strategy. Diabetes care expert Robert Gabbay, MD, PhD, FACP was appointed as chair of the Pivot Innovation Council. The council will provide insights on target patient populations, support optimization of clinical workflows, inform evidence-generation initiatives, and help refine the Pivot product roadmap and go-to-market approach, as the Company continues to scale its differentiated offering.

Modular released findings (July 15) from an independent market research study demonstrating positive receptivity to its FDA-cleared Pivot™ tubeless patch pump due to its differentiated design, streamlined user experience, and potential for reimbursement through the pharmacy channel.

LG Display Co., Ltd. (LPL)

LG Display Co., Ltd. (NYSE: LPL, $3, +.67%) has spent the last few years doing something many hardware companies talk about but few execute well: turning a technology pivot into a full‑blown business transformation that everyday investors can actually follow. Instead of chasing commoditized LCD TV panels in a race to the bottom, LPL is leaning into Gaming OLED, CES‑worthy innovation, and premium automotive displays – and the press trail tells a surprisingly investor‑friendly story.

Yatsen Group (NYSE: YSG)

Yatsen Group (NYSE: YSG, $2.53), a leading China-based beauty group, delivered the sort of quarter that can make a turnaround investor sit up straighter: reported revenue grew, its strategically important skincare operation accelerated sharply, and the company is increasingly built around clinical and premium brands rather than a pure color-cosmetics play. The results are not yet a victory lap, losses widened and third-quarter guidance is cautious, but YSG’s transformation is beginning to look less like a cosmetic touch-up and more like a genuine renovation.

YSG announced (July 8) a landmark collaboration to bring its flagship brand, Perfect Diary, to Sephora in China. This partnership integrates Yatsen’s rigorous scientific infrastructure with the world’s leading prestige beauty retailer, marking a significant milestone in Yatsen’s continuing evolution into a global beauty technology powerhouse.

Doximity, Inc. (NYSE:DOCS)

Doximity (NYSE: DOCS, $26.20) is the leading digital platform for U.S. medical professionals. The company’s network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits.

Doximity, Inc. (NYSE: DOCS) announced (Aug. 6) results of its fiscal 2027 first quarter ended June 30, 2026. Jeff Tangney, co-founder and CEO of Doximity, “We’re proud that our clinical AI assistant, Doximity Ask, was the top-performing U.S.-based model in the NOHARM benchmark while we delivered another quarter of record engagement. In Q1 we had accelerated revenue growth along with workflow active prescriber growth of more than 30% year-over-year and AI Search query growth of over 25% quarter-over-quarter.”

Fiscal 2027 First Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended June 30, 2025.

• Revenue: Revenue of $156.6 million, versus $145.9 million, an increase of 7% year-over-year.
• Net income and non-GAAP net income: Net income of $24.3 million, versus $53.3 million, representing a margin of 15.5%, versus 36.5%. Non-GAAP net income of $55.0 million, versus $71.9 million, representing a margin of 35.1%, versus 49.2%.
• Adjusted EBITDA: Adjusted EBITDA of $74.8 million, versus $79.8 million, a decrease of 6% year-over-year, representing adjusted EBITDA margins of 47.7%, versus 54.7%.
• Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.13, versus $0.27, while non-GAAP diluted net income per share was $0.29, versus $0.36.
• Operating cash flow and free cash flow: Operating cash flow of $42.0 million, versus $62.1 million, a decrease of 32% year-over-year, and free cash flow of $39.6 million, versus $60.1 million, a decrease of 34% year-over-year.

Financial Outlook

Doximity is providing guidance for its fiscal second quarter ending September 30, 2026 as follows:

• Revenue between $170 million and $171 million.
• Adjusted EBITDA between $80.5 million and $81.5 million.

Doximity is updating guidance for its fiscal year ending March 31, 2027 as follows:

• Revenue between $671 million and $681 million.
• Adjusted EBITDA between $309 million and $329 million.

Sable Offshore Corp. (SOC)

Sable Offshore Corp. (NYSE: SOC, $3.57) has moved from the awkward “pre-revenue restoration project” phase into something much more recognizable to Wall Street: a company selling meaningful volumes of oil, generating operating cash flow, and building momentum into a potentially larger 2027 earnings base. The second-quarter report on Monday was not a polished victory lap—midstream bottlenecks and one-time costs made sure of that, but it offered something potentially more valuable: proof that the Santa Ynez Unit restart is translating into barrels, revenue, and operational traction. Learn more.

Nvidia (NVDA, $228.86,+1.68%)

NVIDIA Corp. (NASDAQ: NVDA) seemingly has given many a two-part bullish signal: a record-sized $150 billion increase to its share-repurchase authorization and a new AI-agent safety platform aimed at making autonomous software more secure for enterprise deployment. The combination suggests a company using extraordinary financial strength not merely to reward shareholders, but to expand its influence from AI computing into the governance, security and operating layer of the AI economy. The timing is notable. Markets are beginning the week with a cautiously constructive tone, even as investors brace for jobs, inflation and manufacturing data that could reset the outlook for interest rates. In that environment, NVIDIA is making a familiar but potent argument: its AI franchise is generating enough cash to finance innovation, deepen its ecosystem and return meaningful capital to shareholders, all at once. That is not an everyday corporate trick. It is closer to juggling bowling balls while also building the bowling alley.

The Sources

Sources

1. CNBC Stock Market Today: Live Updates, September 28, 2026
2. CNBC Trump Unveils $15 Billion Mesabi Metallics Iowa Steel Plant
3. CNBC Boeing 737 Max 10 Certification Delayed by Software Issue
4. CNBC LeBron James Boosts Ticket and Merchandise Demand for Philadelphia 76ers
5. CNBC Elon Musk and SpaceXAI Subpoenaed in New York City AI-Safety Investigation
6. CNBC SpaceX Launches Starship Into Orbit for the First Time
7. CNBC Apple Faces $5.7 Billion Patent-Infringement Verdict
8. CNBC Stocks Making the Biggest Moves: MongoDB, Boeing, Kodiak Sciences, Roblox and Nvidia
9. Yahoo Finance AMC Entertainment Announces Pricing of First-Lien Notes and New Term-Loan Facility
10. Yahoo Finance Zenkuda and Tabirafusp-ted Meet Primary Endpoints in DAYBREAK Trial
11. Yahoo Finance Mark Penn Defends American Eagle’s Sydney Sweeney Advertising Campaign
12. Federal Reserve Bank of Dallas September 2026 Texas Manufacturing Outlook Survey
13. Federal Reserve Bank of Dallas September 2026 Manufacturing Survey Results Table
14. Reuters U.S. Stocks Fall as Middle East Stalemate Boosts Oil Prices
15. Reuters Trump to Unveil Planned $15 Billion Iowa Steel Project
16. Reuters Apple Owes Taction Technology $5.7 Billion in Patent Case
17. Reuters SpaceX Starship Reaches Orbit and Deploys Starlink Satellites
18. AMC Entertainment Investor Relations Pricing of First-Lien Notes and New Term-Loan Facility
19. AMC Entertainment September 24, 2026 Form 8-K
20. PR Newswire Kodiak Sciences Reports DAYBREAK Phase 3 Results
21. City & State New York New York City Council Subpoenas SpaceXAI
22. Philadelphia Inquirer 76ers Name Bloom Energy as Jersey-Patch Sponsor
23. Sports Business Journal Philadelphia 76ers Sign Bloom Energy Jersey-Patch Deal
24. SpaceX Investor Relations SpaceX Initial Public Offering and Nasdaq Listing